FactSet Schedules Fourth Quarter 2026 Earnings Call

NORWALK, Conn., Sept. 02, 2026 (GLOBE NEWSWIRE) -- FactSet (NYSE:FDS | NASDAQ: FDS), a leading global intelligence and AI solutions provider to the financial markets, today announced it will release its financial and operating results for the fourth quarter fiscal 2026, ending August 31, 2026, on Wednesday, September 30, 2026.

FactSet will host a conference call at 9:00 a.m. Eastern Time on the same day to discuss the results, followed by a live Q&A session.

Fourth Quarter Fiscal 2026 Conference Call Details

Please register for the conference call using the above link in advance of the call start time. Upon registration, you will receive dial-in information and a unique access PIN.

The earnings presentation will be available on FactSet’s Investor Relations website at 8:30 a.m. Eastern Time on September 30, 2026, 30 minutes before the earnings call begins.

A replay will be available on the Investor Relations website after 1:00 p.m. Eastern Time on September 30, 2026, and will remain accessible through September 30, 2027. A transcript of the earnings call will be available via FactSet CallStreet.

About FactSet

FactSet (NYSE:FDS | NASDAQ: FDS) supercharges financial intelligence, offering enterprise data and information solutions that help our clients maximize their potential. Our digital platform seamlessly integrates proprietary data, third-party sources, and flexible technology to deliver tailored solutions across the buy side, sell side, wealth, and corporate sectors. With over 47 years of expertise, we leverage advanced data connectivity, AI, and next-generation tools to streamline workflows and enable smarter decision-making. As an S&P 500 company serving more than 9,100 global clients and over 247,000 individual users, we are dedicated to innovation and long-term client success. Learn more at www.factset.com and follow us on X and LinkedIn.

FactSet
Investor Relations:
Kevin Toomey
+1.212.209.5259
[email protected]

Media Relations:
Alexandra Shevchenko
[email protected]
+44 07518 131115

You May Also Be Interested In

• S&P shares jump report of potential CapIQ spinout
• BofA downgrades Amrize to underperform, cuts price target on slower growth outlook
• Sell Recreational Cannabis as "Medicine"- Federal Class Action Alleges a "Concerted Campaign"